TELA Bio, Inc. (TELA)
NGM – Real Time Price. Currency in USD
1.02
+0.05 (5.14%)
At close: May 12, 2026, 4:00 PM EDT
0.97
-0.04 (-4.41%)
After-hours: May 12, 2026, 7:45 PM EDT
Find any stock by ticker or company name

NGM – Real Time Price. Currency in USD
1.02
+0.05 (5.14%)
At close: May 12, 2026, 4:00 PM EDT
0.97
-0.04 (-4.41%)
After-hours: May 12, 2026, 7:45 PM EDT
TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient’s anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene, polyglycolic acid, and polylactic-co-glycolic acid designed to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. TELA Bio, Inc. was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.
| Name | Position |
|---|---|
| Mr. Antony Koblish | Co-founder, CEO & Director |
| Mr. D. Taylor Ocasio | General Counsel & Corporate Secretary |
| Mr. Gregory A. Firestone | Chief Business Officer |
| Mr. Jeffrey Blizard | President |
| Mr. Jim Hagen | Senior VP of Strategic Commercial Operations & Marketing |
| Mr. Michael Leonard | Senior Vice President of Technical Operations |
| Mr. Paul Talmo | Chief Technology Officer |
| Mr. Roberto E. Cuca J.D. | CFO, Corporate Secretary & COO |
| Ms. Jennifer Lou Armstrong | Senior Vice President of Human Resources |
| Ms. Megan Smeykal | VP, Corporate Controller, Chief Accounting Officer & Principal Accounting Officer |
| Date | Type | Document |
|---|---|---|
| 2026-04-30 | DEF 14A | tm261452-1_def14a.htm |
| 2026-04-30 | 8-K | tm2612982d1_8k.htm |
| 2026-03-25 | S-8 | tm268780d1_s8.htm |
| 2026-03-24 | 8-K | tm269387d1_8k.htm |
| 2026-03-20 | 8-K | tm269374d1_8k.htm |
| 2025-12-12 | S-3 | tm2532716-1_s3.htm |
| 2025-11-14 | 8-K | tm2531310d1_8k.htm |
| 2025-11-03 | 8-K | tm2530000d1_8k.htm |
| 2025-10-09 | 8-K | tm2528308d1_8k.htm |
| 2025-08-11 | 8-K | tm2522957d1_8k.htm |